Not provided
Not provided
Not provided
Not provided
Not provided
Principal Investigator is making changes to the protocol.
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Robot assisted urological procedures are often long surgical cases that can potentially result in complicated postoperative hospital course. The amount of intravenous (IV) fluids administered to patients during these operations fluctuates based on the length of the case, surgical blood loss, hemodynamic monitors, and the discretion of the anesthesiologist. The goal of intraoperative fluid therapy is to maintain optimal tissue perfusion without causing fluid overload. We plan to use a goal directed fluid therapy protocol to optimize fluid status and analyze post-operative outcomes.
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Control Group | Active Comparator | The control group will be administered intraoperative fluids throughout his or her surgery per the discretion of the anesthesiologist as is typical for this type of case. They will use an arterial line but without a FloTrac and therefore will have no data regarding the SVV. |
|
| Treatment Group | Experimental | The treatment group will receive a FloTrac arterial line that will allow the anesthesiologist to administer intraoperative fluids based on the study algorithm. |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Control Group | Other | Intraoperative fluids will be administer per the discretion of anesthesia provider and not per SVV data or study protocol. |
|
| Measure | Description | Time Frame |
|---|---|---|
| Postoperative ileus | Time postoperatively to first bowel movement | Up to 3 weeks postoperatively |
| Measure | Description | Time Frame |
|---|---|---|
| Acute kidney injury | Will be measured using the KDIGO criteria (UOP and Cr) | Up to 3 weeks postoperatively |
| Respiratory compromise | Patients that require oxygen or invasive/non-invasive mechanical ventilation postoperatively |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Loma Linda University | Loma Linda | California | 92354 | United States |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| ID | Term |
|---|---|
| D007022 | Hypotension |
| D020896 | Hypovolemia |
| D004487 | Edema |
| ID | Term |
|---|---|
| D014652 | Vascular Diseases |
| D002318 | Cardiovascular Diseases |
| D010335 | Pathologic Processes |
| D013568 | Pathological Conditions, Signs and Symptoms |
Not provided
Not provided
| ID | Term |
|---|---|
| D035061 | Control Groups |
| ID | Term |
|---|---|
| D015340 | Epidemiologic Research Design |
| D004812 | Epidemiologic Methods |
| D008919 | Investigative Techniques |
| D012107 | Research Design |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Treatment Group | Other | FloTrac arterial line data will be used to administer fluid bolus, based on study algorithm. |
|
| Up to 3 weeks postoperatively |
| Need for diuresis | Use of a diuretic medication (ex. lasix, metolazone) | Up to 3 weeks postoperatively |
| Hospital length of stay | Duration of stay in the hospital | Up to 4 weeks postoperatively |
| D012816 | Signs and Symptoms |
| D008722 | Methods |